nach oben

Erschienen in:

20.10.2021 | Original Article

Risk of migraine contributed by genetic polymorphisms of ANKDD1B gene: a case–control study based on Chinese Han population

verfasst von: Tianxiao Zhang, Hang Wei, Miao Li, Wei Han, Wenjuan Zhang, Xiaojie Zhang, Bo Zhang, Zhao Jiang, Tao Li

Erschienen in: Neurological Sciences | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Early studies have indicated that the risk of migraine is contributed by both genetic and environmental factors. We aimed to evaluate the association between the risk of migraine and genetic polymorphisms in the ANKDD1B gene in a large sample of Chinese Han populations. A total of 882 patients with MO and 1,784 age-matched controls were recruited. A list of 12 tag SNPs located within the ANKDD1B gene region was genotyped. Distributions of SNP genotypes and alleles between patients and controls were examined to investigate the associations between the risk of migraine and genetic polymorphisms. The GTEx database was used to examine the effects of the significant SNPs on gene expressions. A stop-gain SNP, rs34358, was discovered to be significantly related with the risk of migraine (χ² = 25.02, P = 5.66 × 10⁻⁷). The A allele of this SNP was significantly associated with a decreased risk of migraine (OR [95% CI] = 0.73 [0.65–0.83]). A dose-dependent pattern was identified in the genotypic analyses. The OR with 95% confidence interval for genotype AA versus GG was 0.55 [0.42–0.72], while for AG versus GG it was 0.74 [0.62–0.88]. Further bioinformatics analysis showed multiple significant signals (20 out of 47) for the association between SNP rs34358 and gene expression levels of ANKDD1B. In conclusion, we have provided population-based evidence for the association between genetic polymorphisms of the ANKDD1B gene and the risk of migraine. A protein-truncating variant was significantly associated with a decreased risk of migraine in the samples recruited from the Chinese Han population.

Nur mit Berechtigung zugänglich

Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine–current understanding and treatment. N Engl J Med 346:257–270. https://doi.org/10.1056/NEJMra010917CrossRefPubMed

Pilati L, Battaglia G, Di Stefano V et al (2020) Migraine and Sport in a Physically Active Population of Students: Results of a Cross-Sectional Study. Headache 60(10):2330–2339. https://doi.org/10.1111/head.14015CrossRefPubMed

Lipton RB, Bigal ME (2005) The epidemiology of migraine. Am J Med 118:3S-10S. https://doi.org/10.1016/j.amjmed.2005.01.014CrossRefPubMed

Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365–391. https://doi.org/10.1146/annurev-physiol-030212-183717CrossRefPubMed

GBD (2019) Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9CrossRef

Edvinsson L, Haanes KA, Warfvinge K (2019) Does inflammation have a role in migraine? Nat Rev Neurol 15:483–490. https://doi.org/10.1038/s41582-019-0216-yCrossRefPubMed

Ramachandran R (2018) Neurogenic inflammation and its role in migraine. Semin Immunopathol 40:301–314. https://doi.org/10.1007/s00281-018-0676-yCrossRefPubMed

Hoffmann J, Baca SM, Akerman S (2019) Neurovascular mechanisms of migraine and cluster headache. J Cereb Blood Flow Metab 39:573–594. https://doi.org/10.1177/0271678X17733655CrossRefPubMed

Goadsby PJ (2012) Pathophysiology of migraine. Ann Indian Acad Neurol 15:S15–S22. https://doi.org/10.4103/0972-2327.99993CrossRefPubMedPubMedCentral

10.

Di Stefano V, Ornello R, Gagliardo A et al (2021) Social Distancing in Chronic Migraine during the COVID-19 Outbreak: Results from a Multicenter Observational Study. Nutrients 13(4):1361. https://doi.org/10.3390/nu13041361CrossRefPubMedPubMedCentral

11.

Polderman TJ, Benyamin B, de Leeuw CA, Sullivan PF, van Bochoven A, Visscher PM, Posthuma D (2015) Meta-analysis of the heritability of human traits based on fifty years of twin studies. Nat Genet 47:702–709. https://doi.org/10.1038/ng.3285CrossRefPubMed

12.

Buniello A, MacArthur JAL, Cerezo M et al (2019) The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res 47:D1005–D1012. https://doi.org/10.1093/nar/gky1120CrossRefPubMed

13.

Kowalska M, Prendecki M, Kozubski W, Lianeri M, Dorszewska J (2016) Molecular factors in migraine. Oncotarget 7(31):50708–50718CrossRefPubMedPubMedCentral

14.

Barbanti P, Brighina F, Egeo G, Di Stefano V, Silvestro M, Russo A (2020) Migraine as a Cortical Brain Disorder. Headache 60(9):2103–2114. https://doi.org/10.1111/head.13935CrossRefPubMed

15.

Di Stefano V, Rispoli MG, Pellegrino N et al (2020) Diagnostic and therapeutic aspects of hemiplegic migraine. J Neurol Neurosurg Psychiatry 91(7):764–771. https://doi.org/10.1136/jnnp-2020-322850CrossRefPubMed

16.

Schmutz J, Martin J, Terry A et al (2004) The DNA sequence and comparative analysis of human chromosome 5. Nature 431:268–274. https://doi.org/10.1038/nature02919CrossRefPubMed

17.

Yang Y, Zhao H, Boomsma DI et al (2018) Molecular genetic overlap between migraine and major depressive disorder. Eur J Hum Genet 26:1202–1216. https://doi.org/10.1038/s41431-018-0150-2CrossRefPubMedPubMedCentral

18.

Guo Y, Rist PM, Daghlas I et al (2020) A genome-wide cross-phenotype meta-analysis of the association of blood pressure with migraine. Nat Commun 11:3368. https://doi.org/10.1038/s41467-020-17002-0CrossRefPubMedPubMedCentral

19.

Enis A, Dannon B, Vdb M et al (2016) The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2016 update. Nucleic Acids Res 44:W3–W10. https://doi.org/10.1093/nar/gkw343CrossRef

20.

Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265. https://doi.org/10.1093/bioinformatics/bth457CrossRefPubMed

21.

Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575. https://doi.org/10.1086/519795CrossRefPubMedPubMedCentral

22.

GTEx Consortium (2013) The Genotype-Tissue Expression (GTEx) project. Nat Genet 45:580–585. https://doi.org/10.1038/ng.2653CrossRef

23.

Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY (2004) The ankyrin repeat as molecular architecture for protein recognition. Protein Sci 13:1435–1448. https://doi.org/10.1110/ps.03554604CrossRefPubMedPubMedCentral

24.

Li J, Mahajan A, Tsai MD (2006) Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45:15168–15178. https://doi.org/10.1021/bi062188qCrossRefPubMed

25.

Islam Z, Nagampalli RSK, Fatima MT, Ashraf GM (2018) New paradigm in ankyrin repeats: Beyond protein-protein interaction module. Int J Biol Macromol 109:1164–1173. https://doi.org/10.1016/j.ijbiomac.2017.11.101CrossRefPubMed

26.

König HG, Schwamborn R, Andresen S, Kinsella S, Watters O, Fenner B, Jhm Prehn (2017) NF-κB regulates neuronal ankyrin-G via a negative feedback loop. Sci Rep 7:42006. https://doi.org/10.1038/srep42006CrossRefPubMedPubMedCentral

27.

Pulit SL, Stoneman C, Morris AP et al (2019) Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet 28:166–174. https://doi.org/10.1093/hmg/ddy327CrossRefPubMed

28.

Vujkovic M, Keaton JM, Lynch JA et al (2020) Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat Genet 52:680–691. https://doi.org/10.1038/s41588-020-0637-yCrossRefPubMedPubMedCentral

29.

Surendran P, Drenos F, Young R et al (2016) Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat Genet 48:1151–1161. https://doi.org/10.1038/ng.3654CrossRefPubMedPubMedCentral

30.

Wojcik GL, Graff M, Nishimura KK et al (2019) Genetic analyses of diverse populations improves discovery for complex traits. Nature 570:514–518. https://doi.org/10.1038/s41586-019-1310-4CrossRefPubMedPubMedCentral

31.

UniProt Consortium (2021) UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res 49:D480–D489. https://doi.org/10.1093/nar/gkaa1100CrossRef

32.

Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, Sirotkin K (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311. https://doi.org/10.1093/nar/29.1.308CrossRefPubMedPubMedCentral

33.

Reuter U, Chiarugi A, Bolay H, Moskowitz MA (2002) Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol 51:507–516. https://doi.org/10.1002/ana.10159CrossRefPubMed

34.

Greco R, Tassorelli C, Cappelletti D, Sandrini G, Nappi G (2005) Activation of the transcription factor NF-kappaB in the nucleus trigeminalis caudalis in an animal model of migraine. Neurotoxicology 26:795–800. https://doi.org/10.1016/j.neuro.2005.02.005CrossRefPubMed

35.

Rivera-Mancilla E, Al-Hassany L, Villalón CM, MaassenVanDenBrink A (2021) Metabolic Aspects of Migraine: Association With Obesity and Diabetes Mellitus. Front Neurol 12:686398. https://doi.org/10.3389/fneur.2021.686398CrossRefPubMedPubMedCentral

36.

Guan F, Zhang T, Han W et al (2020) Relationship of SNAP25 Variants With Schizophrenia and Antipsychotic-Induced Weight Change in Large-Scale Schizophrenia Patients. Schizophr Res 215:250–255. https://doi.org/10.1016/j.schres.2019.09.015CrossRefPubMed

37.

Han W, Zhang TX, Ni T et al (2018) Relationship of common variants in CHRNA5 with early-onset schizophrenia and executive function. Schizophr Res 206:407–412. https://doi.org/10.1016/j.schres.2018.10.011CrossRefPubMed

38.

Guan F, Ni T, Han W et al (2020) Evaluation of the relationships of the WBP1L gene with schizophrenia and the general psychopathology scale based on a case-control study. Am J Med Genet B Neuropsychiatr Genet 183:164–171. https://doi.org/10.1002/ajmg.b.32773CrossRefPubMed

39.

Guan F, Ni T, Zhu W, et al. (2021) Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction. Molecular Psychiatry 2021. https://doi.org/10.1038/s41380-021-01201-2

40.

Chen J, Zheng H, Bei JX et al (2009) Genetic structure of the Han Chinese population revealed by genome-wide SNP variation. Am J Hum Genet 85:775–785. https://doi.org/10.1016/j.ajhg.2009.10.016CrossRefPubMedPubMedCentral

Titel: Risk of migraine contributed by genetic polymorphisms of ANKDD1B gene: a case–control study based on Chinese Han population
verfasst von: Tianxiao Zhang
Hang Wei
Miao Li
Wei Han
Wenjuan Zhang
Xiaojie Zhang
Bo Zhang
Zhao Jiang
Tao Li
Publikationsdatum: 20.10.2021
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 4/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05645-w

Four pedigrees with aminoacyl-tRNA synthetase abnormalities

Original Article

Focal and asymmetric triceps brachii weakness: a rare but possible myasthenia gravis presentation

Letter to the Editor

Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis

Original Article

Brain-computer interface as complementary therapy for hemiparesis in an astrocytoma patient

Letter to the Editor

Neurophysiological and ultrasonographic comparative study of autonomous nervous system in patients suffering from fibromyalgia and generalized anxiety disorder

Original Article

Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability

Brief Communication

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

18.04.2025
AAN-Jahrestagung 2025
Nachrichten

Eine Therapie mit dem C40-Ligand-Blocker Frexalimab kann MS-Schübe und neue MRT-Läsionen über zwei Jahre hinweg verhindern. Dafür spricht die Auswertung einer offen fortgeführten Phase-2-Studie.

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

17.04.2025
AAN-Jahrestagung 2025
Nachrichten

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Schadet Schichtarbeit dem Gehirn?

17.04.2025
AAN-Jahrestagung 2025
Kongressbericht

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Risk of migraine contributed by genetic polymorphisms of ANKDD1B gene: a case–control study based on Chinese Han population

Abstract

Weitere Artikel der Ausgabe 4/2022

Four pedigrees with aminoacyl-tRNA synthetase abnormalities

Focal and asymmetric triceps brachii weakness: a rare but possible myasthenia gravis presentation

Genetic analysis in Chinese patients with familial or young-onset amyotrophic lateral sclerosis

Brain-computer interface as complementary therapy for hemiparesis in an astrocytoma patient

Neurophysiological and ultrasonographic comparative study of autonomous nervous system in patients suffering from fibromyalgia and generalized anxiety disorder

Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Schadet Schichtarbeit dem Gehirn?

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten